Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.Hopkins, C.R., O'neil, S.V., Laufersweiler, M.C., Wang, Y., Pokross, M., Mekel, M., Evdokimov, A., Walter, R., Kontoyianni, M., Petrey, M.E., Sabatakos, G., Roesgen, J.T., Richardson, E., Demuth Jr., T.P.
(2006) Bioorg Med Chem Lett 16: 5659-5663
- PubMed: 16919947
- DOI: https://doi.org/10.1016/j.bmcl.2006.08.003
- Primary Citation of Related Structures:
- PubMed Abstract:
The synthesis and structure-activity relationships of a novel series of N-sulfonyl-2-indole carboxamides that bind to peroxisome proliferator-activated receptor gamma (PPAR-gamma) are reported. Chemical optimization of the series led to the identification of 4q (IC(50)=50 nM) as a potent binding agent of PPAR-gamma. Also reported is preliminary cell based data suggesting the use of these compounds in the treatment of osteoporosis.
Procter and Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Mason OH 45040, USA. Corey.Hopkins@sanofi-aventis.com